MedPath
FDA Approval

PRAVASTATIN SODIUM

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
DirectRX
DUNS: 079254320
Effective Date
January 21, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pravastatin(20 mg in 1 1)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

DirectRX

DirectRX

079254320

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PRAVASTATIN SODIUM

Product Details

NDC Product Code
61919-731
Application Number
ANDA076939
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 21, 2020
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61UClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
POVIDONEInactive
Code: FZ989GH94EClass: IACT
MAGNESIUM ALUMINUM SILICATEInactive
Code: 6M3P64V0NCClass: IACT
TALCInactive
Code: 7SEV7J4R1UClass: IACT
Code: 3M8608UQ61Class: ACTIBQuantity: 20 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath